Royal UNIBREW A/S
Share buy-back program completed
Share buy-back program completed
On February 25, 2025, Royal Unibrew initiated a share buy-back program, as announced in company announcement no. 3/2025. The program has now been successfully completed.
The program was carried out in accordance with Art. 5 of Regulation (EU) No 596/2014 of the European Parliament and Council of April 16, 2014 (MAR) and the Commission Delegated Regulation (EU) No 2016/1052 of March 8, 2016, also referred to as the Safe Harbour Regulations.
The share buy-back program was carried out from February 26, 2025, to August 15, 2025, with a maximum transaction value of the share buy-backs of DKK 250m.
The following transactions on Nasdaq Copenhagen A/S have been made under the program:
Number of Shares | Average purchase price DKK | Transaction value, DKK | |
Accumulated, last announcement | 457,806 | 533.65 | 244,308,655 |
August 11, 2025 | 2,300 | 482.39 | 1,109,499 |
August 12, 2025 | 2,300 | 480.32 | 1.104.,738 |
August 13, 2025 | 2,400 | 477.51 | 1,146,036 |
August 14, 2025 | 2,500 | 473.22 | 1,183,039 |
August 15, 2025 | 2,414 | 475.46 | 1,147,767 |
Total accumulated under the program | 469,720 | 532.23 | 249,999,734 |
With the transactions stated above Royal Unibrew owns a total of 603,042 shares, corresponding to 1.2% of the share capital. The total amount of shares in the company is 50,200,000, including treasury shares.
For further information please contact:
Flemming Ole Nielsen (Head of Investor Relations)
E-mail: Flemming.Nielsen@royalunibrew.com
Telephone: +45 25 41 68 04
Encl.
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Cosmos Health Inc.18.8.2025 18:45:23 CEST | Press release
Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025
ONWARD Medical NV18.8.2025 18:30:00 CEST | Press release
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System
INSPIRED AI PTE. LTD.18.8.2025 18:19:13 CEST | Press release
TalkMe Brings a Penguin to Life at Google I/O, Redefining AI Language Learning
Vaisala Group18.8.2025 17:30:00 CEST | Press release
Vaisala Corporation: Share Repurchase 18.8.2025
Baltic Horizon Fund / Northern Horizon Capital18.8.2025 16:45:00 CEST | Press release
Baltic Horizon Fund General Meeting – notice to investors
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom